Posts by james.stahl@sketchdecker.com
A New Approach to Prescription Drug Negotiation is Emerging
For years, the U.S. pharmacy benefits system has relied on complex pricing structures that obscure the true cost of medications and make it hard for employers and patients to navigate their prescription drug benefits. Years of rising prescription drug costs in the U.S. has placed financial strain on employers, patients, and the broader healthcare system.…
Read MoreA Smarter Way to Lower Drug Costs: How Transparency and Innovation Can Redesign Pharmacy Benefits
Crippling drug costs is uniquely an American burden, with the U.S. paying 2.5 times more for medications than those in other high-income nations. This weighs heavily on consumers and businesses. According to a recent KFF poll, 82% of Americans say drug prices are unreasonable, and three in ten adults report not taking their medications as prescribed because…
Read MoreIntroducing Synergie Medication Collective
A note from Jarrod Henshaw, Synergie Chief Executive Officer.
Read MoreBlues plans launch Synergie to cut costs for the priciest drugs
Synergie Medication Collective, an independent company the plans see as a novel solution to costly physician-administered drugs.
Read MoreAnnouncing Synergie Medication Collective
Blue Cross Blue Shield companies form Synergie Medication Collective, a new venture to radically improve affordability and access to costly medications for millions.
Read More